Hidemaru Yamaguchi
Stock Analyst at Citi
(1.18)
# 3,491
Out of 4,345 analysts
63
Total ratings
46.3%
Success rate
-1.8%
Average return
Main Sectors:
Stocks Rated by Hidemaru Yamaguchi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4506 Sumitomo Pharma Co., Ltd. | Maintained: Sell | ¥1,260 → ¥1,500 | $1,524.00 | -1.57% | 5 | May 25, 2026 | |
| TYO: 4503 Astellas Pharma Inc. | Maintained: Hold | ¥2,500 → ¥2,400 | $2,138.00 | +12.25% | 3 | May 1, 2026 | |
| TYO: 2503 Kirin Holdings Company, Limited | Downgraded: Hold | ¥2,800 | $2,735.50 | +2.36% | 1 | Apr 3, 2026 | |
| TYO: 4587 PeptiDream Inc. | Downgraded: Hold | ¥3,300 → ¥1,600 | $1,143.50 | +39.92% | 2 | Mar 12, 2026 | |
| TYO: 4151 Kyowa Kirin Co., Ltd. | Downgraded: Sell | ¥3,800 → ¥2,000 | $2,470.50 | -19.04% | 2 | Mar 10, 2026 | |
| TYO: 2413 M3, Inc. | Maintained: Buy | ¥2,600 → ¥2,800 | $1,402.00 | +99.71% | 6 | Feb 9, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Maintained: Buy | ¥5,800 → ¥4,900 | $2,714.50 | +80.51% | 6 | Feb 5, 2026 | |
| TYO: 4552 JCR Pharmaceuticals Co., Ltd. | Maintained: Hold | ¥600 → ¥670 | $497.00 | +34.81% | 4 | Feb 5, 2026 | |
| TYO: 4565 Nxera Pharma Co., Ltd. | Maintained: Buy | ¥1,100 → ¥1,400 | $1,105.00 | +26.70% | 5 | Nov 28, 2025 | |
| TYO: 4523 Eisai Co., Ltd. | Maintained: Buy | ¥5,900 → ¥6,200 | $4,023.00 | +54.11% | 5 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,800 → ¥3,900 | $2,432.00 | +60.36% | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,200 → ¥3,500 | $3,707.00 | -5.58% | 2 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥1,750 | $2,375.50 | -26.33% | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥10,400 → ¥10,500 | $11,155.00 | -5.87% | 3 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥5,100 → ¥4,600 | $4,083.00 | +12.66% | 3 | Aug 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥2,600 | $1,895.50 | +37.17% | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥4,200 → ¥3,500 | $3,835.00 | -8.74% | 2 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥2,410 | $2,758.50 | -12.63% | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥960 | $1,089.00 | -11.85% | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥830 | $1,142.00 | -27.32% | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥2,600 | $2,889.00 | -10.00% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥12,000 | $7,779.00 | n/a | 1 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ¥3,100 → ¥2,800 | $3,029.00 | n/a | 2 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ¥3,300 | $1,397.00 | n/a | 1 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $31.12 | n/a | 1 | Mar 29, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $22.40 | n/a | 1 | Nov 18, 2009 |
Sumitomo Pharma Co., Ltd.
May 25, 2026
Maintained: Sell
Price Target: ¥1,260 → ¥1,500
Current: $1,524.00
Upside: -1.57%
Astellas Pharma Inc.
May 1, 2026
Maintained: Hold
Price Target: ¥2,500 → ¥2,400
Current: $2,138.00
Upside: +12.25%
Kirin Holdings Company, Limited
Apr 3, 2026
Downgraded: Hold
Price Target: ¥2,800
Current: $2,735.50
Upside: +2.36%
PeptiDream Inc.
Mar 12, 2026
Downgraded: Hold
Price Target: ¥3,300 → ¥1,600
Current: $1,143.50
Upside: +39.92%
Kyowa Kirin Co., Ltd.
Mar 10, 2026
Downgraded: Sell
Price Target: ¥3,800 → ¥2,000
Current: $2,470.50
Upside: -19.04%
M3, Inc.
Feb 9, 2026
Maintained: Buy
Price Target: ¥2,600 → ¥2,800
Current: $1,402.00
Upside: +99.71%
Daiichi Sankyo Company, Limited
Feb 5, 2026
Maintained: Buy
Price Target: ¥5,800 → ¥4,900
Current: $2,714.50
Upside: +80.51%
JCR Pharmaceuticals Co., Ltd.
Feb 5, 2026
Maintained: Hold
Price Target: ¥600 → ¥670
Current: $497.00
Upside: +34.81%
Nxera Pharma Co., Ltd.
Nov 28, 2025
Maintained: Buy
Price Target: ¥1,100 → ¥1,400
Current: $1,105.00
Upside: +26.70%
Eisai Co., Ltd.
Sep 12, 2025
Maintained: Buy
Price Target: ¥5,900 → ¥6,200
Current: $4,023.00
Upside: +54.11%
Aug 29, 2025
Maintained: Buy
Price Target: ¥3,800 → ¥3,900
Current: $2,432.00
Upside: +60.36%
Aug 29, 2025
Maintained: Buy
Price Target: ¥3,200 → ¥3,500
Current: $3,707.00
Upside: -5.58%
Aug 28, 2025
Maintained: Hold
Price Target: ¥1,750
Current: $2,375.50
Upside: -26.33%
Aug 27, 2025
Maintained: Buy
Price Target: ¥10,400 → ¥10,500
Current: $11,155.00
Upside: -5.87%
Aug 26, 2025
Maintained: Buy
Price Target: ¥5,100 → ¥4,600
Current: $4,083.00
Upside: +12.66%
Aug 22, 2025
Maintained: Buy
Price Target: ¥2,600
Current: $1,895.50
Upside: +37.17%
Aug 22, 2025
Maintained: Buy
Price Target: ¥4,200 → ¥3,500
Current: $3,835.00
Upside: -8.74%
Jun 26, 2025
Maintained: Hold
Price Target: ¥2,410
Current: $2,758.50
Upside: -12.63%
Jun 26, 2025
Maintained: Hold
Price Target: ¥960
Current: $1,089.00
Upside: -11.85%
Jun 26, 2025
Maintained: Hold
Price Target: ¥830
Current: $1,142.00
Upside: -27.32%
Jun 24, 2025
Downgraded: Hold
Price Target: ¥2,600
Current: $2,889.00
Upside: -10.00%
May 27, 2025
Maintained: Buy
Price Target: ¥12,000
Current: $7,779.00
Upside: n/a
May 21, 2025
Maintained: Buy
Price Target: ¥3,100 → ¥2,800
Current: $3,029.00
Upside: n/a
Nov 26, 2024
Maintained: Hold
Price Target: ¥3,300
Current: $1,397.00
Upside: n/a
Mar 29, 2010
Upgraded: Buy
Price Target: n/a
Current: $31.12
Upside: n/a
Nov 18, 2009
Upgraded: Hold
Price Target: n/a
Current: $22.40
Upside: n/a